Equinox Group

Website Links

Description

We are able to provide unbiased, data-driven analysis with quick turnaround to meet client needs. We can assess business development targets in the clinic and estimate their future market success. Equinox Group is able to provide a rapid investigation of an asset’s clinical innovation and potential.

Since its inception in 1995, Equinox Group has worked with its clients to develop customized solutions to their most complex problems.

We also have deep experience in rare and orphan diseases , and have built a model to estimate pricing potential in these indications based on prevalence, disease seriousness, and the clinical innovation offered by a new product. In oncology , we have developed specialized tools to solve the problems that arise in evaluating the outlook for new drugs to treat cancer.

Founded in 1995, Equinox Group specializes in assessing the commercial outlook for drugs to help pharmaceutical and biotechnology companies make better business decisions. We offer innovative analysis, cutting-edge forecasting techniques, and deep experience to help our clients evaluate opportunities in all therapeutic areas.

Teams responsible for setting strategy and evaluating assets in a therapeutic area face many challenges, including assessing the merit of programs targeted to specific diseases and helping management decide what to fund. We have years of experience working with client teams to elicit insights that inform their strategy.

Fact sheet

Products & services

Similar companies nearby